The Europe generic drug market was valued at $61.1 billion in 2023 and is projected to grow to $110.8 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2032. Key drivers of this growth include the rising prevalence of chronic diseases like diabetes and cardiovascular conditions, advancements in drug formulation such as fixed-dose combinations, cost-... https://www.imarcgroup.com/europe-generic-drug-market